Log in for full access to this activity, if you are registered.

Registration Options

Activity Dates: 04/30/2012 - 04/30/2015

This course is closed. Please look for other available products in CPNP University.

Session Summary

Pharmacists are situated to play a key role in preventing prescription drug misuse and abuse by providing clear information and advice about how to take a medication appropriately, about the effects the medication may have, and about possible drug interactions. This two hour session will educate pharmacists how to develop collaborative practices with prescribers in order to play an important role in deterring prescription drug abuse by ensuring Universal Precautions are used when controlled substances are prescribed. Patients with current or a past history of substance abuse who are being treated for pain often present therapeutic dilemmas. This session will provide an evidence-based review of the literature to prepare pharmacists to provide valuable guidance in developing a care plan for this special population.

Course Requirements

You will proceed through the following steps to satisfactorily complete this course:

  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date. (login first)
  • Complete the evaluation at the end of the activity. (login first)
  • Receive a passing grade (60%).
  • Provide the necessary details in your profile to ensure correct reporting by CPNP to CPE Monitor. (login first)

This session was presented live at the 2012 CPNP Annual Meeting. A PDF file of the slides and audio of the speaker’s presentation is provided. ACPE transcripts can be retrieved by participants online at cpnp.org and the credit will be automatically submitted to your account at CPE Monitor shortly after the evaluation is completed.

Faculty Information and Disclosures

S. Hughes Melton, MD, FAAFP
Merrill Norton, PharmD, DPh, ICCDP-D

View biographical information and disclosures

Learning Objectives

  1. Apply appropriate risk assessment strategies (i.e., Risk Evaluation and Mitigation Strategies [REMS], Universal Precautions) for the abuse, misuse, and diversion of opioid therapies used in the management of chronic pain.
  2. Select screening instruments to identify patients at risk for opioid dependence and/or abuse.
  3. Evaluate abuse-deterrent technologies associated with opioid therapy.
  4. Evaluate evidence-based literature for patient-related factors associated with risk of relapse if opioid medications are used to treat pain in patients with a history of addiction.
  5. Formulate a response to challenges encountered in the management of chronic pain in patients at risk for, or with a history of, addiction.
  6. Contrast options for pharmacotherapy (e.g., nonsteroidal anti-inflammatory drugs [NSAIDs], opioid therapies, adjunctive agents) for chronic pain in patients at risk for, or with a history of, addiction.

Continuing Education Credit and Disclosures

Activity Dates: 04/30/2012 - 04/30/2015
ACPE Contact Hours: 2.0
ACPE Number: 0284-9999-12-009-H04-P (Application)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPE Credit

The College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

 

CME Credit

Sponsored by the University of Arizona College of Medicine at the Arizona Health Sciences Center.

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the Joint sponsorship of The University of Arizona College of Medicine at the Arizona Health Sciences Center and the College of Psychiatric and Neurologic Pharmacists. ACCME credit is no longer available for this course.

Nursing Credit

ACPE and ACCME approved contact hours are accepted for ANCC Certification Renewal (as quoted on the ANCC website):  “Other health disciplines' continuing education hours may be used if the content is applicable to your area of certification. ACPE and ACCME are specifically listed as approved credit types.

Grant Support

Annual Meeting Grant Supporter

Cyberonics

Genentech

BCPP Recertification Grant Supporter

Merck
Genentech
Lilly

This activity is supported by an educational grant from Lilly USA, LLC. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.